Sign in
4

Changes in Ownership

CUMBERLAND PHARMACEUTICALS INC Filed Acc 0001209191-15-083595

VP and Chief Compliance Office acquired 5,775 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Herman James L VP and Chief Compliance Office 2015-12-02 Grant or award +5,775 $5.58 $32,225 41,467 D
Loading xslF345X03/doc4.xml…